The prospect of the ECB jumping the gun on the Fed reined in the euro somewhat on Friday, but the dollar has generally been a casualty of the stepped-up easing expectations and its index hit the lowest since mid January.
That’s mainly because the Bank of Japan is heading in the opposite direction – likely tightening its super-loose monetary policy as soon as this month and sending the yen to its best levels in five weeks.
Amid a series of press rumblings and official statements this week, Reuters sources on Friday said growing number of BOJ policymakers had warmed to the idea of ending negative interest rates in March as the annual wage round looks set to be robust.
But they added that some still urge a delay until April to wait for next month’s “tankan” business sentiment survey and the bank’s regional branch managers’ report on the wage outlook.
After Thursday’s setback, however, Japan’s Nikkei stock benchmark brushed off the speculation and rose 0.2%.
Stocks gained in China too, encouraged by this week’s upbeat trade numbers and as the country’s securities regulator vowed to protect small investors by cracking down on market misbehaviour and improving the quality of listed companies.
And on Friday Bloomberg reported that China is in the process of raising more than $27 billion for its largest chip fund to date to accelerate the development of cutting-edge technologies to counter a U.S. campaign to thwart its rise.
Elsewhere in politics, President Joe Biden late Thursday laid out his case for re-election in a fiery State of the Union speech that accused Donald Trump of threatening democracy, kowtowing to Russia and torpedoing a bill to tackle U.S. immigration woes.
In company news, the soundings were more mixed overnight.
Broadcom said it expects $10 billion in revenue from chips related to artificial intelligence this year, but its stock dipped after the tech company’s full-year forecast failed to impress investors. Smaller rival Marvell Technology forecast revenue below market expectations, sending its stock down over 6% in extended trading.
There was better news for the ailing New York Community Bank, whose shares perked up after it said it’s seeing interest from non-bank bidders for some of its loans and will outline a new business plan next month.
And in Europe, Novo Nordisk on Thursday surpassed Tesla in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly anticipated new obesity drug.